Skip to content
Black Friday — 30% OFFFree shipping on orders of £99 or more
  1. Home
  2. Hormonal Health & Growth
  3. S23 + S4 + GW-501516 Value Pack
Hormonal Health

S23 + S4 + GW-501516 Value Pack

This research bundle combines three synthetic compounds frequently studied together in selective receptor and metabolic pathway research: S4 (Andarine), a synthetic research molecule studied for selective molecular pathway interactions; S-23, studied for specific receptor binding properties; and GW-501516 (Cardarine), studied for metabolic pathway modulation.

Presentation: S23 + S4 + GW-501516 Value Pack.

Illustrative packaging generated with AI.

Original price was: £205.85.Current price is: £144.10.

Available on request in the United Kingdom

Ask an advisor
An advisor contacts you and the partner pharmacy checks whether and how it can proceed. A valid prescription, or an assessment through an authorised telemedicine service, may be required.
  • Partner pharmacy
  • Personal assistance
  • Discreet delivery
  • Presentation
    S23 + S4 + GW-501516 Value Pack

Shipping & Delivery

  • Normally dispatched within 24 hours of payment confirmation.
  • USPS Regular Shipping · £11.95 · Approx. 3–5 business days
  • FedEx 2 Days Delivery · £28.99 · Approx. 2 business days
  • FedEx Overnight Delivery · £40.99 · Approx. 1 business day

For laboratory research only.

Not for human or veterinary use.

Composition and product details

Overview

This research bundle combines three synthetic compounds frequently studied together in selective receptor and metabolic pathway research: S4 (Andarine), a synthetic research molecule studied for selective molecular pathway interactions; S-23, studied for specific receptor binding properties; and GW-501516 (Cardarine), studied for metabolic pathway modulation.

Combined research models allow investigation into how multiple selective receptor compounds and a metabolic modulator may intersect within body composition and metabolic efficiency research. Research applications include comparative selective receptor pathway studies and multi-compound metabolic research design.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only
All SwissChems products are independently third-party tested at a USA-based HPLC-licensed laboratory prior to distribution. Certificates of Analysis (COA) are published on the Independent Test Results page and available at product level. If any independently conducted HPLC test returns a negative result, SwissChems will refund: (1) the cost of the HPLC test, and (2) the full order amount including shipping.

Properties

Synonyms S4 + S23 + GW-501516 Value Pack
Shelf Life 36 months

Research

This value pack pairs S4 (Andarine), a synthetic research molecule designed for investigating selective molecular pathways, with S-23, a selective non-steroidal compound studied for specific receptor binding properties in laboratory models, and GW-501516 (Cardarine), a research compound studied for metabolic pathway modulation including glucose transport and lipid metabolism research. Combined research protocols examining all three compounds allow investigation into how two structurally distinct selective receptor modulators and a metabolic pathway compound may interact within multi-pathway body composition and metabolic efficiency research models. Each compound is independently third-party HPLC-tested; COA available per batch.

FAQ

How do S4 and S-23 differ in their proposed receptor pathway research applications compared to each other?

S4 (Andarine) and S-23 are both studied for selective receptor binding properties but represent structurally distinct compounds within this research category, allowing comparative research into how subtle structural differences influence receptor selectivity and downstream pathway engagement when studied within the same experimental protocol.

What experimental models are used to study this three-compound combination’s effects on receptor and metabolic pathways?

Cell-based receptor binding and selectivity assays, alongside metabolic flux measurements (such as glucose uptake and lipid oxidation assays) for the GW-501516 component, are standard methods for studying this combination, typically compared across single-compound and combined-compound treatment arms.

How should researchers structure comparative protocols using this three-compound value pack?

Factorial or staggered experimental designs incorporating single-compound, paired-compound, and full three-compound treatment arms allow researchers to isolate the contribution of each compound and identify any combination-specific effects on selected receptor and metabolic research endpoints.

Original price was: £205.85.Current price is: £144.10.